1
|
de Troya‐Martín M, Rodríguez‐Martínez A, Rivas‐Ruiz F, Subert A, Arellano‐Mendoza M, Calzavara‐Pinton P, de Gálvez MV, Gilaberte Y, Goh C, Lim HW, Schalka S, Wolf P, González S. Personalized Photoprotection: Expert Consensus and Recommendations From a Delphi Study Among Dermatologists. PHOTODERMATOLOGY, PHOTOIMMUNOLOGY & PHOTOMEDICINE 2025; 41:e70001. [PMID: 39868505 PMCID: PMC11771696 DOI: 10.1111/phpp.70001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/04/2024] [Revised: 12/12/2024] [Accepted: 12/12/2024] [Indexed: 01/28/2025]
Abstract
BACKGROUND Recommending comprehensive personalized photoprotection requires an accurate assessment of the patient's skin, including phototype, lifestyle, exposure conditions, environmental factors, and concomitant cutaneous conditions as well as deep knowledge of the available options: sunscreen ingredients (type of filters, spectrum coverage, sun protection factor, enhanced active ingredients), oral photoprotection, and other methods of sun protection and avoidance. OBJECTIVES To establish consensus-based recommendations endorsed by an international panel of experts for personalized medical photoprotection recommendations that are applicable globally. METHODS A two-round Delphi study was designed to determine the degree of agreement and relevance of aspects related to personalized medical photoprotection. Items with ≥ 80% agreement and relevance were considered approved. RESULTS A list of 28 recommendations for personalized medical photoprotection was approved by a panel of dermatology professionals from seven different countries. Recommendations were categorized as: (1) updated perspectives in photoprotection, (2) clinical management, (3) skin cancer prevention, (4) dark skin phototypes and skin prone to hyperpigmentation, and (5) age and lifestyle. CONCLUSION This study established recommendations for the implementation of personalized medical photoprotection worldwide, highlighting areas needing further scientific and clinical evidence.
Collapse
Affiliation(s)
| | | | | | - Andras Subert
- Research and Innovation UnitCosta del Sol University HospitalMarbellaSpain
| | | | | | | | - Yolanda Gilaberte
- Department of DermatologyHospital Universitario Miguel Servet, IIS AragonZaragozaSpain
| | - Chee‐Leok Goh
- National Skin CentreSingapore National Skin CentreSingapore
| | - Henry W. Lim
- Division of Photobiology and Photomedicine, Department of DermatologyHenry Ford HealthDetroitMichiganUSA
| | - Sergio Schalka
- Photoprotection LaboratoryMedicine Skin Research CenterSão PauloBrazil
| | - Peter Wolf
- Dermatology DepartmentMedical University of GrazGrazAustria
| | - Salvador González
- Department of Medicine and Medical SpecialtiesUniversity of Alcalá de HenaresMadridSpain
| |
Collapse
|
2
|
Sousa K, Picada JN, da Silva GR, Solka LDC, de Oliveira IM, Henriques JAP, Campo LF, Corrêa DS. Innovative Photoprotection Strategy: Development of 2-(Benzoxazol-2-Yl)[(2-Hydroxynaphthyl)Diazenyl] Phenol Derivatives for Comprehensive Absorption of UVB, UVA, and Blue Light. Chem Biol Drug Des 2024; 104:e70020. [PMID: 39567468 DOI: 10.1111/cbdd.70020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2024] [Revised: 10/30/2024] [Accepted: 11/04/2024] [Indexed: 11/22/2024]
Abstract
Overexposure to blue light due to the excessive use of electronic devices has been implicated in premature skin aging and eye damage, among other injuries to health. This study aimed to synthesize two azo derivatives of the 2-(amino-2'-hydroxyphenyl) benzoxazole and explore their potential as UV and blue light filters, proposing a new spectral profile. The synthesis of the heterocyclic compounds involved condensation reactions and diazotation. The derivatives 2-(benzoxazol-2-yl)-5-[(2-hydroxynaphthyl)diazenyl]phenol and 2-(benzoxazol-2-yl)-4-[(2-hydroxynaphthyl)diazenyl]phenol were synthesized with a yield greater than 70%. Solubility was evaluated in seven different solvents. The maximum absorption wavelengths (λmax) were determined using UV-Vis scanning spectrophotometry in the range of 200-600 nm. Photostability was assessed using a solar simulator and the Sun protection factor (SPF) was determined using in vitro methodology. Cytotoxicity was evaluated using the MTT assay in V79 cells. These compounds were able to absorb UVA, UVB, and blue light, with λmax ranging from 300 to 500 nm and demonstrated photostability after 3 h of exposure to solar simulator with an SPF higher than 45. The compounds exhibited solubility in all lipophilic solvents tested. Regarding cytotoxicity, IC50 values were comparable to other filters. These findings indicate that both compounds hold promise as potential organic filters.
Collapse
Affiliation(s)
- Karen Sousa
- Laboratory of Genetic Toxicology, Lutheran University of Brazil (ULBRA), Canoas, RS, Brazil
- Center for Research in Product and Development (CEPPED), Lutheran University of Brazil (ULBRA), Canoas, RS, Brazil
| | | | - Gabriela Rodrigues da Silva
- Center for Research in Product and Development (CEPPED), Lutheran University of Brazil (ULBRA), Canoas, RS, Brazil
| | - Larissa da Cunha Solka
- Center for Research in Product and Development (CEPPED), Lutheran University of Brazil (ULBRA), Canoas, RS, Brazil
| | - Iuri Marques de Oliveira
- Department of Biophysics, Biotechnology Center, Federal University of Rio Grande Do Sul (UFRGS), Porto Alegre, RS, Brazil
| | - João Antonio Pêgas Henriques
- Department of Biophysics, Biotechnology Center, Federal University of Rio Grande Do Sul (UFRGS), Porto Alegre, RS, Brazil
- Postgraduate Program in Biotechnology and Medical Sciences, University of Vale Do Taquari (UNIVATES), Lajeado, RS, Brazil
| | - Leandra Franciscato Campo
- Laboratory of New Organic Materials and Forensic Chemistry, Federal University of Rio Grande Do Sul (UFRGS), Porto Alegre, RS, Brazil
| | - Dione Silva Corrêa
- Center for Research in Product and Development (CEPPED), Lutheran University of Brazil (ULBRA), Canoas, RS, Brazil
| |
Collapse
|
3
|
Gallego-Rentero M, López Sánchez A, Nicolás-Morala J, Alcaraz-Laso P, Zhang N, Juarranz Á, González S, Carrasco E. The effect of Fernblock® in preventing blue-light-induced oxidative stress and cellular damage in retinal pigment epithelial cells is associated with NRF2 induction. Photochem Photobiol Sci 2024; 23:1471-1484. [PMID: 38909335 DOI: 10.1007/s43630-024-00606-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2024] [Accepted: 06/13/2024] [Indexed: 06/24/2024]
Abstract
Blue light exposure of the ocular apparatus is currently rising. This has motivated a growing concern about potential deleterious effects on different eye structures. To address this, ARPE-19 cells were used as a model of the retinal pigment epithelium and subjected to cumulative expositions of blue light. The most relevant cellular events previously associated with blue-light-induced damage were assessed, including alterations in cell morphology, viability, cell proliferation, oxidative stress, inflammation, and the induction of DNA repair cellular mechanisms. Consistent with previous reports, our results provide evidence of cellular alterations resulting from repeated exposure to blue light irradiation. In this context, we explored the potential protective properties of the vegetal extract from Polypodium leucotomos, Fernblock® (FB), using the widely known treatment with lutein as a reference for comparison. The only changes observed as a result of the sole treatment with either FB or lutein were a slight but significant increase in γH2AX+ cells and the raise in the nuclear levels of NRF2. Overall, our findings indicate that the treatment with FB (similarly to lutein) prior to blue light irradiation can alleviate blue-light-induced deleterious effects in RPE cells, specifically preventing the drop in both cell viability and percentage of EdU+ cells, as well as the increase in ROS generation, percentage of γH2AX+ nuclei (more efficiently with FB), and TNF-α secretion (the latter restored only by FB to similar levels to those of the control). On the contrary, the induction in the P21 expression upon blue light irradiation was not prevented neither by FB nor by lutein. Notably, the nuclear translocation of NRF2 induced by blue light was similar to that observed in cells pre-treated with FB, while lutein pre-treatment resulted in nuclear NRF2 levels similar to control cells, suggesting key differences in the mechanism of cellular protection exerted by these compounds. These results may represent the foundation ground for the use of FB as a new ingredient in the development of alternative prophylactic strategies for blue-light-associated diseases, a currently rising medical interest.
Collapse
Affiliation(s)
- María Gallego-Rentero
- Department of Biology, Faculty of Sciences, Universidad Autónoma de Madrid, Madrid, Spain
- Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
| | | | - Jimena Nicolás-Morala
- Department of Biology, Faculty of Sciences, Universidad Autónoma de Madrid, Madrid, Spain
- Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
| | - Paula Alcaraz-Laso
- Department of Biology, Faculty of Sciences, Universidad Autónoma de Madrid, Madrid, Spain
| | - Noelia Zhang
- Department of Biology, Faculty of Sciences, Universidad Autónoma de Madrid, Madrid, Spain
| | - Ángeles Juarranz
- Department of Biology, Faculty of Sciences, Universidad Autónoma de Madrid, Madrid, Spain
- Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
| | - Salvador González
- Department of Medicine and Medical Specialties, Alcalá de Henares University, Madrid, Spain.
| | - Elisa Carrasco
- Department of Biology, Faculty of Sciences, Universidad Autónoma de Madrid, Madrid, Spain.
- Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
- Centro de Biología Molecular Severo Ochoa (CBM); Instituto Universitario de Biología Molecular-IUBM (Universidad Autónoma de Madrid), Madrid, Spain.
| |
Collapse
|
4
|
Gracia-Cazaña T, Aguilera J, Navarro-Bielsa A, González S, Lim HW, Gilaberte Y. New trends on personalized sunscreens. PHOTODERMATOLOGY, PHOTOIMMUNOLOGY & PHOTOMEDICINE 2024; 40:e12967. [PMID: 38616500 DOI: 10.1111/phpp.12967] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/29/2023] [Revised: 03/18/2024] [Accepted: 04/02/2024] [Indexed: 04/16/2024]
Abstract
BACKGROUND/PURPOSE Nowadays, there are emerging trends in customized and personalized photoprotection, focusing on the innovative approaches to enhance sun protection efficacy tailored to individual needs. METHODS We conducted an electronic search of the following databases: MEDLINE, EMBASE, Cochrane Database of Systematic Reviews, Cochrane Skin Group Specialised Skin Register, and TESEO. Specific search terms related to personalized photoprotection and the variables of age, genetic predisposition, skin phototype, photodermatosis, and physiological conditions such as pregnancy, as well as lifestyle habits were used. RESULTS/CONCLUSION The article highlights the challenges and opportunities in adopting personalized photoprotection strategies, aiming to promote skin health and prevent the harmful effects of UV radiation in the era of precision medicine.
Collapse
Affiliation(s)
- Tamara Gracia-Cazaña
- Department of Dermatology, Miguel Servet University Hospital, IIS Aragón, Zaragoza, Spain
- Department of Medicine, Psychiatry and Dermatology, University of Zaragoza, Zaragoza, Spain
| | - José Aguilera
- Department of Dermatology and Medicine, Faculty of Medicine, Photobiological Dermatology Laboratory, Medical Research Center, University of Malaga, Malaga, Spain
| | - Alba Navarro-Bielsa
- Department of Dermatology, Miguel Servet University Hospital, IIS Aragón, Zaragoza, Spain
- Department of Medicine, Psychiatry and Dermatology, University of Zaragoza, Zaragoza, Spain
| | | | - Henry W Lim
- Department of Dermatology, Henry Ford Health Systems, Henry Ford Medical Center-New Center One, Detroit, Michigan, USA
| | - Yolanda Gilaberte
- Department of Dermatology, Miguel Servet University Hospital, IIS Aragón, Zaragoza, Spain
- Department of Medicine, Psychiatry and Dermatology, University of Zaragoza, Zaragoza, Spain
| |
Collapse
|